The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
about
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)Genetic variation: effect on prostate cancer.The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts.Erectile dysfunction and the risk of prostate cancer.Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.
P2860
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The SRD5A2 V89L polymorphism i ...... h early onset prostate cancer.
@en
The SRD5A2 V89L polymorphism i ...... h early onset prostate cancer.
@nl
type
label
The SRD5A2 V89L polymorphism i ...... h early onset prostate cancer.
@en
The SRD5A2 V89L polymorphism i ...... h early onset prostate cancer.
@nl
prefLabel
The SRD5A2 V89L polymorphism i ...... h early onset prostate cancer.
@en
The SRD5A2 V89L polymorphism i ...... h early onset prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
The SRD5A2 V89L polymorphism i ...... h early onset prostate cancer.
@en
P2093
Anthony Y Smith
Eric Treat
Frances Alba
Harold Nelson
John K Scariano
P2860
P304
P356
10.1002/PROS.20842
P50
P577
2008-12-01T00:00:00Z